ASPEN AEROGELS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.1 USD | +2.48% |
|
+7.62% | +2.03% |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 188.6 | 448.4 | 1,647 | 780.2 | 1,204 | 1,236 | - | - |
| Enterprise Value (EV) 1 | 188.1 | 435.6 | 1,647 | 780.2 | 1,180 | 1,279 | 1,553 | 1,236 |
| P/E ratio | -12.9 x | -20.1 x | -40.8 x | -5.61 x | -23.9 x | -84.7 x | 22.8 x | 12.2 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 1.35 x | 4.47 x | 13.5 x | 4.33 x | 5.04 x | 3.41 x | 2.09 x | 1.46 x |
| EV / Revenue | 1.35 x | 4.34 x | 13.5 x | 4.33 x | 4.94 x | 3.53 x | 2.63 x | 1.46 x |
| EV / EBITDA | -1,075 x | -68.4 x | -63.4 x | -12.9 x | -51.4 x | 39.3 x | 12.6 x | 6.84 x |
| EV / FCF | -59.4 x | -32.7 x | -50.8 x | -2.86 x | -5.41 x | -9.3 x | -14.4 x | -13.4 x |
| FCF Yield | -1.68% | -3.06% | -1.97% | -34.9% | -18.5% | -10.8% | -6.97% | -7.44% |
| Price to Book | 3.2 x | 6.84 x | 11.8 x | 1.05 x | 2.47 x | 2.58 x | 2.25 x | - |
| Nbr of stocks (in thousands) | 24,300 | 26,868 | 33,079 | 66,173 | 76,318 | 76,762 | - | - |
| Reference price 2 | 7.760 | 16.69 | 49.79 | 11.79 | 15.78 | 16.10 | 16.10 | 16.10 |
| Announcement Date | 2/20/20 | 2/18/21 | 2/17/22 | 2/15/23 | 2/12/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 139.4 | 100.3 | 121.6 | 180.4 | 238.7 | 362.1 | 591 | 844.9 |
| EBITDA 1 | -0.175 | -6.367 | -25.98 | -60.64 | -22.93 | 32.58 | 122.8 | 180.8 |
| EBIT 1 | -14.16 | -21.57 | -40.6 | -79.24 | -49.2 | -5.593 | 69.59 | 124.4 |
| Operating Margin | -10.16% | -21.51% | -33.38% | -43.94% | -20.61% | -1.54% | 11.78% | 14.72% |
| Earnings before Tax (EBT) 1 | -14.56 | -21.81 | -37.09 | -82.74 | -45.81 | -14.27 | 55.54 | 123 |
| Net income 1 | -14.56 | -21.81 | -37.09 | -82.74 | -45.81 | -14.27 | 54.69 | 106.7 |
| Net margin | -10.45% | -21.75% | -30.5% | -45.87% | -19.19% | -3.94% | 9.25% | 12.63% |
| EPS 2 | -0.6000 | -0.8300 | -1.220 | -2.100 | -0.6600 | -0.1900 | 0.7075 | 1.315 |
| Free Cash Flow 1 | -3.166 | -13.34 | -32.41 | -272.4 | -218.1 | -137.6 | -108.2 | -92 |
| FCF margin | -2.27% | -13.3% | -26.64% | -151.01% | -91.35% | -38% | -18.3% | -10.89% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 2/20/20 | 2/18/21 | 2/17/22 | 2/15/23 | 2/12/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 30.38 | 31.48 | 38.41 | 45.64 | 36.71 | 59.61 | 45.59 | 48.16 | 60.76 | 84.22 | 75.37 | 83.96 | 96.46 | 106.4 | 121.9 |
| EBITDA 1 | -7.83 | -12.15 | -14.67 | -18.32 | -23.19 | -4.464 | -13.94 | -10.83 | -7.295 | 9.132 | 2.337 | 6.562 | 10.5 | 13.08 | 20.47 |
| EBIT 1 | -11.5 | -16.31 | -18.62 | -22.65 | -28.31 | -9.666 | -18.91 | -17.04 | -14.63 | 1.383 | -7.29 | -3.658 | 1.35 | 4.164 | 4.1 |
| Operating Margin | -37.85% | -51.83% | -48.49% | -49.62% | -77.12% | -16.22% | -41.48% | -35.39% | -24.09% | 1.64% | -9.67% | -4.36% | 1.4% | 3.91% | 3.36% |
| Earnings before Tax (EBT) 1 | -7.822 | -16.35 | -19.48 | -24.05 | -29.6 | -9.609 | -16.8 | -15.42 | -13.07 | -0.519 | -9.044 | -5.497 | -1.018 | 1.276 | 1 |
| Net income 1 | -7.822 | -16.35 | -19.48 | -24.05 | -29.6 | -9.609 | -16.8 | -15.42 | -13.07 | -0.519 | -8.276 | -4.94 | -0.8407 | 0.5617 | 1.684 |
| Net margin | -25.75% | -51.96% | -50.73% | -52.7% | -80.63% | -16.12% | -36.84% | -32.03% | -21.52% | -0.62% | -10.98% | -5.88% | -0.87% | 0.53% | 1.38% |
| EPS 2 | -0.2400 | -0.5000 | -0.5900 | -0.6800 | -0.7500 | -0.2000 | -0.2400 | -0.2200 | -0.1900 | -0.0100 | -0.1088 | -0.0662 | -0.0150 | 0.006250 | 0.0550 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 10/28/21 | 2/17/22 | 4/27/22 | 7/27/22 | 10/26/22 | 2/15/23 | 5/3/23 | 8/2/23 | 11/1/23 | 2/12/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | 43.5 | 317 | - |
| Net Cash position 1 | 0.51 | 12.8 | - | - | 24.7 | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | 1.335 x | 2.581 x | - |
| Free Cash Flow 1 | -3.17 | -13.3 | -32.4 | -272 | -218 | -138 | -108 | -92 |
| ROE (net income / shareholders' equity) | -22.5% | -34.4% | -21.1% | -28.9% | -9.79% | -2.2% | 10.7% | - |
| ROA (Net income/ Total Assets) | -14.4% | -21.7% | -29.1% | -19.9% | -6.8% | -1.5% | 8.95% | - |
| Assets 1 | 101.3 | 100.5 | 127.4 | 414.8 | 673.2 | 951.5 | 611.1 | - |
| Book Value Per Share 2 | 2.430 | 2.440 | 4.220 | 11.30 | 6.380 | 6.240 | 7.170 | - |
| Cash Flow per Share 2 | -0.0400 | -0.3800 | -0.6100 | -2.400 | -0.6100 | 0.3500 | 1.430 | - |
| Capex 1 | 2.11 | 3.42 | 13.8 | 178 | 175 | 78.8 | 237 | 168 |
| Capex / Sales | 1.52% | 3.41% | 11.33% | 98.67% | 73.5% | 21.75% | 40.07% | 19.89% |
| Announcement Date | 2/20/20 | 2/18/21 | 2/17/22 | 2/15/23 | 2/12/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
16.1
USD
Average target price
20.3
USD
Spread / Average Target
+26.09%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +2.03% | 1.24B | |
| +11.47% | 63.22B | |
| -3.47% | 46.34B | |
| +13.72% | 39.97B | |
| +17.83% | 25.46B | |
| +7.27% | 18.68B | |
| -0.57% | 17.24B | |
| -21.73% | 15.81B | |
| +0.22% | 14.9B | |
| -19.10% | 13.74B |
- Stock Market
- Equities
- ASPN Stock
- Financials Aspen Aerogels, Inc.
